MINIMAL SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLO ARTHRITIS OVER 2 YEARS OF BIMEKIZUMAB TREATMENT: RESULTS FROM A PHASE 3 OPEN-LABEL EXTENSION STUDY

被引:0
|
作者
Baraliakos, X. [1 ]
Ramiro, S. [2 ,3 ]
Maksymowych, W. P. [4 ]
Ostergaard, M. [5 ,6 ]
Massow, U. [7 ]
Fleurinck, C. [8 ]
Vaux, T. [9 ]
Prajapati, C. [9 ]
Marten, A. [7 ]
de Peyrecave, N. [8 ]
Poddubnyy, D. [10 ,11 ]
机构
[1] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet Herne, Bochum, Germany
[2] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands
[3] Zuyderland Med Ctr, Heerlen, Netherlands
[4] Univ Alberta, Dept Med, Edmonton, AB, Canada
[5] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[6] Rigshosp, Copenhagen Ctr Arthrit Res, Ctr Rheumatol, Glostrup, Denmark
[7] UCB Pharma, Monheim, Germany
[8] UCB Pharma, Brussels, Belgium
[9] UCB Pharma, Slough, Berks, England
[10] Charite Univ Med Berlin, Dept Gastroenterol Infect Dis & Rheumatol, Berlin, Germany
[11] German Rheumatism Res Ctr, Dept Epidemiol, Berlin, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P70
引用
收藏
页码:69 / 70
页数:2
相关论文
共 50 条
  • [21] TOFACITINIB, AN ORAL JAK INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND CLINICAL AND RADIOGRAPHIC EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDIES OVER 7 YEARS
    Wollenhaupt, J.
    Silverfield, J.
    Lee, E. B.
    Terry, K. K.
    Kwok, K.
    Lazariciu, I.
    Nduaka, C.
    Connell, C. A.
    DeMasi, R.
    Wang, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 252 - 252
  • [22] Bimekizumab Long-Term Efficacy and Safety over 96 Weeks in Patients with Ankylosing Spondylitis: Interim Results from a Phase 2b Open-Label Extension Study
    Baraliakos, Xenofon
    Deodhar, Atul
    Dougados, Maxime
    Oortgiesen, Marga
    de Peyrecave, Natasha
    Bauer, Martin
    Vaux, Thomas
    Fleurinck, Carmen
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [23] COMPLEMENT ACTIVATION AND SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS TREATED WITH TNF-INHIBITION OVER 2 YEARS: OBSERVATIONS FROM A RANDOMIZED CONTROLLED TRIAL (CONSUL)
    Mistegaard, C. E.
    Troldborg, A.
    Torgutalp, M.
    Loft, A. L.
    Thiel, S.
    Muche, B.
    Rodriguez, Rios, V
    Protopopov, M.
    Listing, J.
    Sieper, J.
    Poddubnyy, D.
    Proft, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 9 - 9
  • [24] Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial
    Strober, Bruce
    Tada, Yayoi
    Mrowietz, Ulrich
    Lebwohl, Mark
    Foley, Peter
    Langley, Richard G.
    Warren, Richard B.
    Wang, Maggie
    Vanvoorden, Veerle
    Szilagyi, Balint
    Ciaravino, Valerie
    Paul, Carle
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (06) : 749 - 759
  • [25] Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study
    Coates, Laura C.
    McInnes, Iain B.
    Merola, Joseph F.
    Warren, Richard B.
    Kavanaugh, Arthur
    Gottlieb, Alice B.
    Gossec, Laure
    Assudani, Deepak
    Bajracharya, Rajan
    Coarse, Jason
    Ink, Barbara
    Ritchlin, Christopher T.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (12) : 1959 - 1970
  • [26] EVALUATION OF RESPONSE TO PNEUMOCOCCAL VACCINATION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING UPADACITINIB: RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY
    Winthrop, K.
    Ignacio Vargas, J.
    Drescher, E.
    Garcia Garcia, C.
    Friedman, A.
    Enejosa, J.
    Khan, N.
    Li, Y.
    Klaff, J.
    Kivitz, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 486 - 487
  • [27] Evaluation of Response to Pneumococcal Vaccination in Patients with Rheumatoid Arthritis Receiving Upadacitinib: Results from a Phase 2 Open-Label Extension Study
    Winthrop, Kevin
    Vargas, Juan
    Drescher, Edit
    Garcia, Conrado
    Friedman, Alan
    Enejosa, Jeffrey
    Khan, Nasser
    Li, Yihan
    Klaff, Justin
    Kivitz, Alan
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [28] Analysis of Integrated Radiographic Data From Two Long-Term, Open-Label Extension Studies of Adalimumab for the Treatment of Rheumatoid Arthritis
    Landewe, Robert
    Ostergaard, Mikkel
    Keystone, Edward C.
    Florentinus, Stefan
    Liu, Shufang
    van der Heijde, Desiree
    ARTHRITIS CARE & RESEARCH, 2015, 67 (02) : 180 - 186
  • [29] PHASE 2 OPEN-LABEL EXTENSION STUDY WITH DONIDALORSEN TREATMENT IN PATIENTS WITH HEREDITARY ANGIOEDEMA
    Bordone, L.
    Riedl, M.
    Newman, K.
    Lui, C.
    Alexander, V.
    Schneider, E.
    Cohn, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S33 - S33
  • [30] Effect of Secukinumab on Radiographic Progression Through 2 Years in Patients with Active Psoriatic Arthritis: End-of-study Results from a Phase III Study
    Mease, Philip
    Landewe, Robert B. M.
    Rahman, Proton
    Tahir, Hasan
    Singhal, Atul
    Boettcher, Elke
    Navarra, Sandra
    Readie, Aimee
    Mpofu, Shephard
    Delicha, Evie Maria
    Pricop, Luminita
    van der Heijde, Desiree
    ARTHRITIS & RHEUMATOLOGY, 2019, 71